Association of caspase-9 and RUNX3 with inflammatory bowel disease

Tissue Antigens

Volumn 77, Issue 1, 2011, Pages 23-29

  Guo, C ^a,b,c   Ahmad, T ^c   Beckly, J ^b,c   Cummings, J R F ^b,c   Hancock, L ^b,c   Geremia, A ^b,c   Cooney, R ^b,c   Pathan, S ^b,c   Jewell, D P ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

caspase 9; Crohn's disease; Inflammatory bowel disease; RUNX3; Ulcerative colitis

Indexed keywords

CASPASE 9; TRANSCRIPTION FACTOR RUNX;

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENERAL PRACTITIONER; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UNITED KINGDOM;

ADULT; CASPASE 9; CORE BINDING FACTOR ALPHA 3 SUBUNIT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GREAT BRITAIN; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE;

EID: 78650029999     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2010.01569.x     Document Type: Article

References (49)

1. Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005: 6: 376-88.
2. Cho JH, Nicolae DL, Gold LH et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Nat Acad Sci U S A 1998: 95: 7502-7.
3. Cho JH, Nicolae DL, Ramos R et al. Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease. Hum Mol Genet 2000: 9: 1425-32.
4. Cohen MM Jr. Perspectives on RUNX genes: an update. Am J Med Genet A 2009: 149A: 2629-46.
5. Subramaniam MM, Chan JY, Yeoh KG, Quek T, Ito K, Salto-Tellez M. Molecular pathology of RUNX3 in human carcinogenesis. Biochim Biophys Acta 2009: 1796: 315-31.
6. Egawa T. Runx and ThPOK: a balancing act to regulate thymocyte lineage commitment. J Cell Biochem 2009: 107: 1037-45.
7. Inoue K, Shiga T, Ito Y. Runx transcription factors in neuronal development. Neural Dev 2008: 3: 20.
8. Brenner O, Levanon D, Negreanu V et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc Natl Acad Sci U S A 2004: 101: 16016-21.
9. Fainaru O, Shseyov D, Hantisteanu S, Groner Y. Accelerated chemokine receptor 7-mediated dendritic cell migration in Runx3 knockout mice and the spontaneous development of asthma-like disease. Proc Natl Acad Sci U S A 2005: 102: 10598-603.
10. Fainaru O, Woolf E, Lotem J et al. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 2004: 23: 969-79.
11. Domínguez-Soto A, Relloso M, Vega MA, Corbí AL, Puig-Kröger A. RUNX3 regulates the activity of the CD11a and CD49d integrin gene promoters. Immunobiology 2005: 210: 133-9.
12. Woolf E, Brenner O, Goldenberg D, Levanon D, Groner Y. Runx3 regulates dendritic epidermal T cell development. Dev Biol 2007: 303: 703-14.
13. Brady G, Farrell PJ. RUNX3-mediated repression of RUNX1 in B cells. J Cell Physiol 2009: 221: 283-7.
14. Brady G, Whiteman HJ, Spender LC, Farrell PJ. Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J Virol 2009: 83: 6909-16.
15. Setoguchi R, Tachibana M, Naoe Y et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 2008: 319: 822-5.
16. Ohno S, Sato T, Kohu K et al. Runx proteins are involved in regulation of CD122, Ly49 family and IFN-gamma expression during NK cell differentiation. Int Immunol 2008: 20: 71-9.
17. Djuretic IM, Levanon D, Negreanu V, Groner Y, Rao A, Ansel KM. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol 2007: 8: 145-53.
18. Prokunina L, Padyukov L, Bennet A et al. Association of the PD1.3 A allelle of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope. Arthritis Rheum 2004: 50: 1770-3.
19. Helms C, Cao L, Krueger JG et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003: 35: 341-348.
20. Tokuhiro S, Yamada R, Chang X et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003: 35: 341-8.
21. Weersma RK, Zhou L, Nolte IM et al. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5. Inflamm Bowel Dis 2008: 14: 1615-22.
22. Silverberg MS, Cho JH, Rioux JD et al. Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009: 41: 216-20.
23. Peppelenbosch MP, Van Deventer SJH. T cell apoptosis and inflammatory bowel disease. Gut 2004: 53: 1556-8.
24. Ina K, Itoh J, Fukushima K et al. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999: 163: 1081-90.
25. Boirivant M, Marini M, Di Felice G et al. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis. Gastroenterology 1999: 116: 557-65.
26. Doering J, Begue B, Lentze MJ et al. Induction of T lymphocyte apoptosis by sulphasalazine in patients with Crohn's disease. Gut 2004: 53: 1632-8.
27. Itoh J, De La Motte C, Strong SA et al. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001: 49: 35-41.
28. Atreya R, Mudter J, Finotto S et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 2000: 6: 583-8.
29. Bu P, Keshavarzian A, Stone DD et al. Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J Immunol 2001: 166: 6399-403.
30. Fayad R, Brand MI, Stone D, Keshavarzian A, Qiao L. Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. Eur J Immunol 2006: 36: 2215-22.
31. Sturm A, Leite AZ, Danese S et al. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis. Gut 2004: 53: 1624-3.
32. Van Der Woude CJ, Moshage H, Homan M, Kleibeuker JH, Jansen PL, Van Dekken H. Expression of apoptosis related proteins during malignant progression in chronic ulcerative colitis. J Clin Pathol 2005: 58: 811-4.
33. Berndt U, Bartsch S, Philipsen L et al. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis. J Immunol 2007: 179: 295-304.
34. Yu QT, Saruta M, Papadakis KA. Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways. Clin Immunol 2008: 127: 322-9.
35. Di Sabatino A, Pender SL, Jackson CL et al. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies. Gastroenterology 2007: 133: 137-49.
36. Hlavaty T, Pierik M, Henckaerts L et al. Polymorphisms in apoptosis genes predict response to infliximab therapy in luminal and fistulizing Crohn's disease. Aliment Pharmacol Ther 2005: 22: 613-26.
37. Li QL, Ito K, Sakakura C et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002: 109: 113-24.
38. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003: 73: 1162-9.
39. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001: 68: 978-89.
40. Duerr RH, Taylor KD, Brant SR et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006: 314: 1461-3.
41. Rioux JD, Xavier RJ, Taylor KD et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007: 39: 596-604.
42. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007: 447: 661-78.
43. Lee SY, Choi YY, Choi JE et al. Polymorphisms in the caspase genes and the risk of lung cancer. J Thorac Oncol 2010: 5: 1152-8.
44. Liu CY, Wu MC, Chen F et al. A large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis 2010: 31: 1259-63.
45. Theodoropoulos GE, Michalopoulos NV, Panoussopoulos SG, Taka S, Gazouli M. Effects of caspase-9 and survivin Gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas 2010: (Epub 30 March 2010).
46. Lan Q, Morton LM, Armstrong B et al. Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 2009: 114: 264-7.
47. Hosgood HD 3rd, Baris D, Zhang Y et al. Genetic variation in cell cycle and apoptosis related genes and multiple myeloma risk. Leuk Res 2009: 33: 1609-14.
48. Andreoli V, Trecroci F, La Russa A et al. CASP-9: A susceptibility locus for multiple sclerosis in Italy. J Neuroimmunol 2009: 210: 100-3.
49. Sakakura C, Hasegawa K, Miyagawa K et al. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers. Clin Cancer Res 2005: 11: 6479-88.